Financial results for Q2 ended December 31, 2025
Citi Pharma Limited (CPHL) · View CPHL share price and financials
Published
Announcement summary
This page records a Pakistan Stock Exchange corporate announcement from Citi Pharma Limited. Review the original filing for the complete terms and regulatory disclosure.
- Unconsolidated Sales
- 4332566.300
- Unconsolidated Pat
- 404334.184
- Unconsolidated Quarter Eps
- 1.77
- Unconsolidated Cumulative Eps
- 2.66